Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Opinion in Pediatrics|December 19, 2019
The future of cellular immunotherapy for childhood leukemiaChallice L Bonifant, Sarah K TasianHematology/Oncology Clinics of North America|June 30, 2022
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic MalignanciesRuyan Rahnama, Ilias Christodoulou, Challice L BonifantBritish Journal of Haematology|July 24, 2025
CD123-targeting immunotherapeutic approaches in acute myeloid leukaemiaAlexandra Dreyzin, Noa G Holtzman, Challice L BonifantExpert Opinion on Biological Therapy|September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemiaChallice L Bonifant, Mireya Paulina Velasquez, Stephen GottschalkBlood|November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodiesMireya Paulina Velasquez, Challice L Bonifant, Stephen GottschalkJournal of Cellular Biochemistry|September 6, 2007
NHERFs, NEP, MAGUKs, and more: interactions that regulate PTENChallice L Bonifant, Jung-Sik Kim, Todd WaldmanCytotherapy|October 13, 2018
Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cellsSergey N Zolov, Skyler P Rietberg, Challice L BonifantSeminars in Hematology|December 1, 2020
Improving CAR T-cells: The next generationAndrew H Marple, Challice L Bonifant, Nirali N ShahBiorxiv : the Preprint Server for Biology|February 6, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenograftsJun Choe, Sachiv Chakravarti, Natalie J Holl, et al.Cancer Immunology Research|February 21, 2019
T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 ReceptorsEric Krawczyk, Sergey N Zolov, Kevin Huang, et al.Pageof 5